Study Stopped
interim analysis proved that protocol intervention had no preventive effect
Hemidiaphragmatic Paralysis With Diluted Continuous Interscalene Plexus Infusions
Incidence of Hemidiaphragmatic Paralysis Using 0.04% Levobupivacaine for Continuous Interscalene Brachial Plexus Blocks in Arthroscopic Shoulder Surgeries
1 other identifier
observational
30
1 country
1
Brief Summary
Interscalene brachial plexus block (ISB) constitutes the analgesic criterion standard for shoulder surgery. However, it is associated with a high incidence of hemidiaphragmatic paralysis (HDP) that may not be tolerated by patients with chronic pulmonary disease. Continuous ISBs have not avoided this complication with the reported and regularly used local anesthetic dilutions (i.e. 0.125% bupivacaine, 0.25% ropivacaine, etc). This observational study will register the incidence of HDP in continuous interscalene block (CISB) using a very diluted solution of levobupivacaine (0.04%) in patients undergoing arthroscopic shoulder surgery. The main objective of this study is to determine the frequency of HDP the first postoperative day before patient discharge(POD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2018
CompletedFirst Posted
Study publicly available on registry
July 19, 2018
CompletedStudy Start
First participant enrolled
August 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 23, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 23, 2019
CompletedJanuary 23, 2020
January 1, 2020
12 months
July 6, 2018
January 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hemidiaphragmatic paralysis before discharge
Defined as less than 25% of basal diaphragm excursion evaluated with ultrasonography
24 hours after surgery
Secondary Outcomes (18)
Hemidiaphragmatic paralysis after surgery
30 minutes after arrival to post anesthetic care unit (PACU)
Amount of local anesthetic (LA) boluses used before discharge.
24 hours after surgery
Level of static postoperative pain at 30 minutes of arrival to PACU
30 minutes after arrival to PACU
Level of static postoperative pain 1 hour after arrival to PACU
60 minutes after arrival
Level of static postoperative pain 3 hour after arrival to PACU
3 hours after arrival to PACU
- +13 more secondary outcomes
Eligibility Criteria
patients undergoing arthroscopic shoulder surgery and programmed to receive a continuous interscalene block as part of postoperative analgesia
You may qualify if:
- age between 18 and 80 years
- American Society of Anesthesiologists classification 1-3
- body mass index between 20 and 35
You may not qualify if:
- adults who are unable to give their own consent
- pre-existing neuropathy (assessed by history and physical examination)
- coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or prothrombin time ≥ 50)
- renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)
- hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)
- allergy to local anesthetics (LAs)
- pregnancy
- prior surgery in the ipsilateral neck region
- chronic pain conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clínica Las Condes
Santiago, Metropolitan, Chile
Related Publications (4)
Tran DQ, Elgueta MF, Aliste J, Finlayson RJ. Diaphragm-Sparing Nerve Blocks for Shoulder Surgery. Reg Anesth Pain Med. 2017 Jan/Feb;42(1):32-38. doi: 10.1097/AAP.0000000000000529.
PMID: 27941477RESULTChoromanski DW, Patel PS, Frederick JM, Lemos SE, Chidiac EJ. The effect of continuous interscalene brachial plexus block with 0.125% bupivacaine vs 0.2% ropivacaine on pain relief, diaphragmatic motility, and ventilatory function. J Clin Anesth. 2015 Dec;27(8):619-26. doi: 10.1016/j.jclinane.2015.03.006. Epub 2015 Jul 26.
PMID: 26216250RESULTFredrickson MJ, Price DJ. Analgesic effectiveness of ropivacaine 0.2% vs 0.4% via an ultrasound-guided C5-6 root/superior trunk perineural ambulatory catheter. Br J Anaesth. 2009 Sep;103(3):434-9. doi: 10.1093/bja/aep195. Epub 2009 Jul 16.
PMID: 19608563RESULTLloyd T, Tang YM, Benson MD, King S. Diaphragmatic paralysis: the use of M mode ultrasound for diagnosis in adults. Spinal Cord. 2006 Aug;44(8):505-8. doi: 10.1038/sj.sc.3101889. Epub 2005 Dec 6.
PMID: 16331304RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiololgist, Clinical Instructor
Study Record Dates
First Submitted
July 6, 2018
First Posted
July 19, 2018
Study Start
August 10, 2018
Primary Completion
July 23, 2019
Study Completion
July 23, 2019
Last Updated
January 23, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share